Not long ago, doctors were often skeptical when cancer patients who had undergone chemotherapy complained that they were mentally foggy; unable to plan a week’s worth of meals or organize their finances as they could before. Patients called this side effect “chemobrain” and were frustrated by the lack of recognition – or suggested remedies – from their physicians.
by Barbara Virchick
On July 18, 2012, a Cancer Center of Excellence opened in Butaro, Rwanda, as a collaboration between Partners In Health and Dana-Farber/Brigham and Women’s Cancer Center. I was fortunate to have been there during this exciting time, working as part of a three-month fellowship to help train the nursing staff to care for Rwandan cancer patients.
I don’t think any of us were prepared for the explosion of patients who would arrive during the first month we were open.
Cancer scientists use a wide variety of techniques to study the growth and development of tumor cells. Laboratory research often focuses on individual cells or tissue samples, but to learn how cancers grow and respond to therapies in living organisms, scientists rely on other experimental models. In recent years, zebrafish have become the model of choice for studying many cancer types. Dana-Farber’s A. Thomas Look, MD, who uses zebrafish in his own work, explains why.
The gaudy green image you see below is not an avant-garde sculpture, but the most detailed image yet made of the protein “spike” that allows HIV – the virus that causes AIDS – to latch onto and enter human blood cells.
It was glitter and glue when patients, visitors, and Dana-Farber staff gathered on Oct. 4 to create art on an unusual canvas – bras. Hosted by Friends’ Place and Dana-Farber’s Creative Arts Program, the “Decorate a Brassiere” art therapy event allowed attendees to creatively honor Breast Cancer Awareness Month.
Faces of Childhood Cancer: Sarah Levin
Sarah Levin is 11 years old, and has beaten acute lymphoblastic leukemia (ALL) twice. This is her story.
The first time I got diagnosed with ALL I was only three, so I don’t remember that much about it. But what my mom and dad have told me is that it was a really sad and scary time for my family.
Fernando Morales is a student athlete. Last year he was sidelined from the life he knew after he was diagnosed with Ewing sarcoma. Now done with treatment Fernando is back with his teammates, sporting a positive outlook and a new appreciation for life. This is his story.
As a soccer player and member of the track and field team at my high school, running is a big part of my life. But one morning I started getting shooting pains in my knee. All of a sudden walking and running became very difficult. In the blink of an eye I lost a big part of my identity, which hurt almost as much as my leg. Almost.
Caitlynne McGaff is an active 17-year-old. She owes a lot of her mobility to an innovative surgery she had at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center to treat her osteosarcoma. This is her story.
When most people my age talk about a day they’ll never forget, they mention getting their license, or a great sweet sixteen party. For me, it’s a little different.
September is National Childhood Cancer Awareness Month. Beginning next Wednesday, and over the next four weeks, we’ll introduce four children – Caitlynne, Fernando, Sarah and Steven – who while still young, have already overcome one of the biggest challenges of their lives.
These four represent just a few of the many faces of childhood cancer across the United States and the world. We hope you’ll join us in September in honoring all of the children who come to Dana-Farber/Children’s Hospital Cancer Center, as well as their caregivers—doctors, nurses, psychologists, social workers, researchers, administrators and more—who work tirelessly until every child is well.
New Year’s Eve 2010. In a military hospital in Hawaii with much of the staff away for the holidays, Army pilot Ben Groen learned he’d been diagnosed with T cell lymphoblastic non-Hodgkin lymphoma, a rare, aggressive cancer of the white blood cells and lymph nodes. His doctor told him that his treatment – which would need to begin almost immediately and require months of hospitalization – would exceed the capacity of the base’s blood bank.
Aspirin has been around for over 100 years. In the last 50 years, research has shown that regular use of aspirin may prevent heart disease. Now a new study points to aspirin’s effectiveness in preventing and treating cancer.
A recent University of Oxford investigation pooled more than 50 studies to show that regular aspirin use could reduce your chances of developing certain types of cancer, and may be effective in treating some cancers as well. We talked to Charles S. Fuchs, MD, MPH, director of the Gastrointestinal Cancer Center at Dana-Farber for his take on the recent research.
Applying sunscreen to wiggly young children can be a challenge, but sun protection is especially critical for young skin. Babies and young children are especially sensitive to the sun. There are several lines of evidence indicating that burns during youth significantly contribute to melanoma risk. For instance, just one blistering sunburn in childhood more than doubles an individual’s risk of developing melanoma later in life.
Genes don’t cause cancer, but genetic mutations can. Our cells have about 22,000 genes, which consist of DNA packed into chromosomes inside the cell nucleus. These genes control a wide range of functions, including cell growth and division. When the genes misbehave or mutate, cancer can develop. Sometimes these mutations are inherited. In that case, … Read more
Medically reviewed by Mark W. Kieran, MD, PhD, Anupama Narla, MD, and Susan N. Chi, MD Most parents treasure the big moments in a child’s life: first steps, first word, first day of school. I, on the other hand, treasure every moment with my son, Declan – the simple act of eating breakfast together, watching … Read more
Treatment with three relatively new “targeted” cancer drugs has been linked to a slightly elevated chance of fatal side effects, according to a new analysis led by scientists at Dana-Farber. The study looked at three drugs: sorafenib (Nexavar), sunitinib (Sutent), and pazopanib (Votrient). Sorafenib is approved to treat kidney and liver cancer, sunitinib to treat … Read more
As we recognize World Cancer Day today, it’s important to remember that one-third of cancer deaths worldwide are tied to lifestyle and diet, making them largely preventable. Dr. Judy Garber, director of Dana-Farber’s Center for Cancer Genetics and Prevention, provides some perspective, and highlights some of the steps individuals can take to reduce their cancer … Read more